Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

2.

Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.

Plotch SJ, O'Hara B, Morin J, Palant O, LaRocque J, Bloom JD, Lang SA Jr, DiGrandi MJ, Bradley M, Nilakantan R, Gluzman Y.

J Virol. 1999 Jan;73(1):140-51.

3.

Novel and specific respiratory syncytial virus inhibitors that target virus fusion.

Ding WD, Mitsner B, Krishnamurthy G, Aulabaugh A, Hess CD, Zaccardi J, Cutler M, Feld B, Gazumyan A, Raifeld Y, Nikitenko A, Lang SA, Gluzman Y, O'Hara B, Ellestad GA.

J Med Chem. 1998 Jul 16;41(15):2671-5. No abstract available.

PMID:
9667956
5.
6.
7.

Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.

Basolo F, Fiore L, Calvo S, Falcone V, Conaldi PG, Fontanini G, Caligo AM, Merlo G, Gluzman Y, Toniolo A.

Br J Cancer. 1996 Jun;73(11):1356-61.

8.

Development of a scintillation proximity assay for human cytomegalovirus protease using 33phosphorous.

Baum EZ, Johnston SH, Bebernitz GA, Gluzman Y.

Anal Biochem. 1996 May 15;237(1):129-34.

PMID:
8660547
9.

Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.

Baum EZ, Ding WD, Siegel MM, Hulmes J, Bebernitz GA, Sridharan L, Tabei K, Krishnamurthy G, Carofiglio T, Groves JT, Bloom JD, DiGrandi M, Bradley M, Ellestad G, Seddon AP, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5847-55.

PMID:
8639546
10.

Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.

Baum EZ, Siegel MM, Bebernitz GA, Hulmes JD, Sridharan L, Sun L, Tabei K, Johnston SH, Wildey MJ, Nygaard J, Jones TR, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5838-46.

PMID:
8639545
11.

[Inhibitory analysis of DNA polymerase of herpes simplex type 1].

Kukhanova MK, Kuznetsova EV, Ias'ko MV, O'Hara B, Bekker J, Morin J, Gluzman Ya.

Mol Biol (Mosk). 1994 Jul-Aug;28(4):875-86. Russian.

PMID:
7990816
12.
13.

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP.

J Med Chem. 1994 Jan 7;37(1):184-8.

PMID:
8289194
14.

cdc2 phosphorylation of threonine 124 activates the origin-unwinding functions of simian virus 40 T antigen.

McVey D, Ray S, Gluzman Y, Berger L, Wildeman AG, Marshak DR, Tegtmeyer P.

J Virol. 1993 Sep;67(9):5206-15.

15.

Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.

Baum EZ, Bebernitz GA, Hulmes JD, Muzithras VP, Jones TR, Gluzman Y.

J Virol. 1993 Jan;67(1):497-506.

16.

Immortalization of virus-free human placental cells that express tissue-specific functions.

Lei KJ, Gluzman Y, Pan CJ, Chou JY.

Mol Endocrinol. 1992 May;6(5):703-12.

PMID:
1318503
18.

Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.

Rasmussen B, Noller HF, Daubresse G, Oliva B, Misulovin Z, Rothstein DM, Ellestad GA, Gluzman Y, Tally FP, Chopra I.

Antimicrob Agents Chemother. 1991 Nov;35(11):2306-11.

19.
20.
21.

Preliminary X-ray crystallographic analysis of a modified basic fibroblast growth factor.

Bollag DM, Seddon AP, Böhlen P, Gluzman Y, Schutt CE.

J Mol Biol. 1991 Apr 5;218(3):493-4.

PMID:
2016739
22.

Cloning, characterization and developmental regulation of two members of a novel human gene family of neurite outgrowth-promoting proteins.

Kretschmer PJ, Fairhurst JL, Decker MM, Chan CP, Gluzman Y, Böhlen P, Kovesdi I.

Growth Factors. 1991;5(2):99-114.

PMID:
1768439
23.

Structure/activity relationships in basic FGF.

Seddon A, Decker M, Müller T, Armellino D, Kovesdi I, Gluzman Y, Böhlen P.

Ann N Y Acad Sci. 1991;638:98-108.

PMID:
1664701
25.

Preferential integration of the Ad5/SV40 hybrid virus at the highly recombinogenic human chromosomal site 1p36.

Romani M, De Ambrosis A, Alhadeff B, Purrello M, Gluzman Y, Siniscalco M.

Gene. 1990 Nov 15;95(2):231-41.

PMID:
2174396
26.

Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636.

Rasmussen BA, Gluzman Y, Tally FP.

Antimicrob Agents Chemother. 1990 Aug;34(8):1590-2.

27.
28.

Properties of the DNA-binding domain of the simian virus 40 large T antigen.

McVey D, Strauss M, Gluzman Y.

Mol Cell Biol. 1989 Dec;9(12):5525-36.

29.

Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.

McVey D, Brizuela L, Mohr I, Marshak DR, Gluzman Y, Beach D.

Nature. 1989 Oct 12;341(6242):503-7.

PMID:
2552322
30.

Large T-antigen mutants define multiple steps in the initiation of simian virus 40 DNA replication.

Mohr IJ, Fairman MP, Stillman B, Gluzman Y.

J Virol. 1989 Oct;63(10):4181-8.

31.

Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigen.

Mohr IJ, Gluzman Y, Fairman MP, Strauss M, McVey D, Stillman B, Gerard RD.

Proc Natl Acad Sci U S A. 1989 Sep;86(17):6479-83.

32.
33.

Studies on the origin-specific DNA-binding domain of simian virus 40 large T antigen.

Strauss M, Argani P, Mohr IJ, Gluzman Y.

J Virol. 1987 Oct;61(10):3326-30.

34.

Analysis of nonpermissivity in mouse cells overexpressing simian virus 40 T antigen.

Gerard RD, Guggenheimer RA, Gluzman Y.

J Virol. 1987 Mar;61(3):851-7.

35.

Regulation of SV40 DNA replication by phosphorylation of T antigen.

Mohr IJ, Stillman B, Gluzman Y.

EMBO J. 1987 Jan;6(1):153-60.

37.

Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors.

Karlsson S, Van Doren K, Schweiger SG, Nienhuis AW, Gluzman Y.

EMBO J. 1986 Sep;5(9):2377-85.

38.
39.

New host cell system for regulated simian virus 40 DNA replication.

Gerard RD, Gluzman Y.

Mol Cell Biol. 1985 Nov;5(11):3231-40.

40.

T antigen and template requirements for SV40 DNA replication in vitro.

Stillman B, Gerard RD, Guggenheimer RA, Gluzman Y.

EMBO J. 1985 Nov;4(11):2933-9.

41.
42.

Duplications of a mutated simian virus 40 enhancer restore its activity.

Herr W, Gluzman Y.

Nature. 1985 Feb 21-27;313(6004):711-4.

PMID:
2983220
43.

Transfer of genes into hematopoietic cells using recombinant DNA viruses.

Karlsson S, Humphries RK, Gluzman Y, Nienhuis AW.

Proc Natl Acad Sci U S A. 1985 Jan;82(1):158-62.

45.
49.

DNA-binding properties of simian virus 40 T-antigen mutants defective in viral DNA replication.

Prives C, Covey L, Scheller A, Gluzman Y.

Mol Cell Biol. 1983 Nov;3(11):1958-66.

50.

Palindromic adenovirus type 5-simian virus 40 hybrid.

Gluzman Y, Van Doren K.

J Virol. 1983 Jan;45(1):91-103.

Supplemental Content

Loading ...
Support Center